{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:10:34Z","timestamp":1760267434164},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,1]]},"DOI":"10.18632\/oncotarget.12115","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T19:04:53Z","timestamp":1474311893000},"page":"71904-71914","source":"Crossref","is-referenced-by-count":7,"title":["MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Wen","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Tianjin Hongqiao Hospital, Tianjin, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Immunology, Tianjin Cancer Institute and Hospital, Tianjin Medical University, P.R. China"},{"name":"National Clinical Research Center of Cancer, P.R. China"},{"name":"Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houfang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Immunology, Tianjin Cancer Institute and Hospital, Tianjin Medical University, P.R. China"},{"name":"National Clinical Research Center of Cancer, P.R. China"},{"name":"Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiubao","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Immunology, Tianjin Cancer Institute and Hospital, Tianjin Medical University, P.R. China"},{"name":"National Clinical Research Center of Cancer, P.R. China"},{"name":"Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pearlie K.","family":"Epling-Burnette","sequence":"additional","affiliation":[{"name":"Immunology Program at the H. Lee Moffitt Cancer Center, Tampa, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Immunology, Tianjin Cancer Institute and Hospital, Tianjin Medical University, P.R. China"},{"name":"National Clinical Research Center of Cancer, P.R. China"},{"name":"Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,19]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00018-015-1846-x","article-title":"The inflammatory microenvironment in MDS","volume":"72","author":"Wei","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"2","first-page":"3557","article-title":"Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes","volume":"54","author":"Toyama","year":"1994","journal-title":"Cancer Res"},{"key":"3","first-page":"1155","article-title":"Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes","volume":"5","author":"Ohyashiki","year":"1999","journal-title":"Clin Cancer Res"},{"key":"4","first-page":"30","article-title":"Telomere biology and telomere diseases: implications for practice and research","volume":"2010","author":"Young","year":"2010","journal-title":"Hematology \/ the Education Program of the American Society of Hematology American Society of Hematology Education Program"},{"key":"5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ejcb.2010.05.005","article-title":"Plk1-mediated mitotic phosphorylation of PinX1 regulates its stability","volume":"89","author":"Huang","year":"2010","journal-title":"Eur J Cell Biol"},{"key":"6","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1073\/pnas.92.20.9082","article-title":"Telomerase activity in normal and malignant hematopoietic cells","volume":"92","author":"de Lange","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3","article-title":"Telomerase activity in human germline and embryonic tissues and cells","volume":"18","author":"Shay","year":"1996","journal-title":"Dev Genet"},{"key":"8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hon.901","article-title":"Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy","volume":"27","author":"Brummendorf","year":"2009","journal-title":"Hematol Oncol"},{"key":"9","first-page":"218","article-title":"Telomerase activity: a prevalent marker of malignant human prostate tissue","volume":"56","author":"Coffey","year":"1996","journal-title":"Cancer Res"},{"key":"10","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood-2010-04-277921","article-title":"T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy","volume":"117","author":"Young","year":"2011","journal-title":"Blood"},{"key":"11","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1182\/blood-2002-01-0096","article-title":"Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities","volume":"100","author":"Young","year":"2002","journal-title":"Blood"},{"key":"12","first-page":"1102","article-title":"Structure and regulation mechanisms of telomerase. [Article in Japanese]","volume":"56","author":"Ishikawa","year":"1998","journal-title":"Nihon Rinsho"},{"key":"13","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.biochi.2013.07.031","article-title":"Physiological and pathological significance of human telomerase reverse transcriptase splice variants","volume":"95","author":"Bollmann","year":"2013","journal-title":"Biochimie"},{"key":"14","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/hmg\/6.12.2011","article-title":"Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types","volume":"6","author":"Jefferson","year":"1997","journal-title":"Hum Mol Genet"},{"key":"15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-1119(99)00108-0","article-title":"Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT)","volume":"232","author":"Hagen","year":"1999","journal-title":"Gene"},{"key":"16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.neo.7900113","article-title":"An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity","volume":"2","author":"Shay","year":"2000","journal-title":"Neoplasia"},{"key":"17","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1093\/nar\/29.23.4818","article-title":"Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells","volume":"29","author":"Wright","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1373\/clinchem.2006.073015","article-title":"Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer","volume":"53","author":"Lianidou","year":"2007","journal-title":"Clin Chem"},{"key":"19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.neo.7900112","article-title":"The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity","volume":"2","author":"Reddel","year":"2000","journal-title":"Neoplasia"},{"key":"20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1593\/neo.08644","article-title":"Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant","volume":"10","author":"Seldon","year":"2008","journal-title":"Neoplasia"},{"key":"21","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1158\/0008-5472.CAN-12-3082","article-title":"The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis","volume":"73","author":"Blackburn","year":"2013","journal-title":"Cancer Res"},{"key":"22","first-page":"4168","article-title":"Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts","volume":"58","author":"Hoffman","year":"1998","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.leukres.2014.04.008","article-title":"Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes","volume":"38","author":"Yang","year":"2014","journal-title":"Leuk Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/leu.2012.300","article-title":"Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency","volume":"27","author":"Epling-Burnette","year":"2013","journal-title":"Leukemia"},{"key":"25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.leukres.2005.03.006","article-title":"Telomerase activity in myelodysplastic syndromes","volume":"29","author":"Baslamisli","year":"2005","journal-title":"Leuk Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4161\/cbt.8.10.8130","article-title":"Increase of telomerase activity and hTERT expression in myelodysplastic syndromes","volume":"8","author":"Ferrero","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"27","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/sj.bjc.6690480","article-title":"Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms","volume":"80","author":"Pisa","year":"1999","journal-title":"Br J Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s005350200061","article-title":"Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues","volume":"37","author":"Ohkawa","year":"2002","journal-title":"J Gastroenterol"},{"key":"29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/ejso.2002.1374","article-title":"hTERT mRNA expression correlates with telomerase activity in human breast cancer","volume":"29","author":"Mokbel","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1046\/j.1365-2141.1998.00969.x","article-title":"Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia","volume":"102","author":"Pisa","year":"1998","journal-title":"Br J Haematol"},{"key":"31","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clinbiochem.2004.05.015","article-title":"Splice variants as cancer biomarkers","volume":"37","author":"Brinkman","year":"2004","journal-title":"Clin Biochem"},{"key":"32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1089\/thy.2008.0101","article-title":"Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms","volume":"18","author":"Zeiger","year":"2008","journal-title":"Thyroid"},{"key":"33","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ajpath.2011.05.056","article-title":"Telomere length is related to alternative splice patterns of telomerase in thyroid tumors","volume":"179","author":"Umbricht","year":"2011","journal-title":"Am J Pathol"},{"key":"34","first-page":"307","article-title":"Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities","volume":"90","author":"Schaich","year":"2005","journal-title":"Haematologica"},{"key":"35","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/1078-0432.CCR-05-0099","article-title":"Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues","volume":"11","author":"Xu","year":"2005","journal-title":"Clin Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.exphem.2013.03.008","article-title":"Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia","volume":"41","author":"Mellstedt","year":"2013","journal-title":"Exp Hematol"},{"key":"37","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.biochi.2010.07.015","article-title":"Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA","volume":"92","author":"Kisseljov","year":"2010","journal-title":"Biochimie"},{"key":"38","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1073\/pnas.96.9.5147","article-title":"Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes","volume":"96","author":"Weng","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1074-7613(00)80597-X","article-title":"Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential","volume":"9","author":"Hodes","year":"1998","journal-title":"Immunity"},{"key":"40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1196\/annals.1392.001","article-title":"Telomere length in human natural killer cell subsets","volume":"1106","author":"Lansdorp","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"key":"41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbi.2007.12.004","article-title":"Reduced telomerase activity in human T lymphocytes exposed to cortisol","volume":"22","author":"Effros","year":"2008","journal-title":"Brain, behavior, and immunity"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:47:54Z","timestamp":1589291274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,19]]},"references-count":41,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2016,11,1]]}},"alternative-id":["12115","27655690"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12115","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,19]]}}}